Development of a rapid insulin assay by homogenous time-resolved fluorescence

Citations of this article
Mendeley users who have this article in their library.


Direct measurement of insulin is critical for basic and clinical studies of insulin secretion. However, current methods are expensive and time-consuming. We developed an insulin assay based on homogenous time-resolved fluorescence that is significantly more rapid and cost-effective than current commonly used approaches. This assay was applied effectively to an insulin secreting cell line, INS-1E cells, as well as pancreatic islets, allowing us to validate the assay by elucidating mechanisms by which dopamine regulates insulin release. We found that dopamine functioned as a significant negative modulator of glucosestimulated insulin secretion. Further, we showed that bromocriptine, a known dopamine D2/ D3 receptor agonist and newly approved drug used for treatment of type II diabetes mellitus, also decreased glucose-stimulated insulin secretion in islets to levels comparable to those caused by dopamine treatment.




Farino, Z. J., Morgenstern, T. J., Vallaghe, J., Gregor, N., Donthamsetti, P., Harris, P. E., … Freyberg, Z. (2016). Development of a rapid insulin assay by homogenous time-resolved fluorescence. PLoS ONE, 11(2).

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free